JP2004527489A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527489A5 JP2004527489A5 JP2002567272A JP2002567272A JP2004527489A5 JP 2004527489 A5 JP2004527489 A5 JP 2004527489A5 JP 2002567272 A JP2002567272 A JP 2002567272A JP 2002567272 A JP2002567272 A JP 2002567272A JP 2004527489 A5 JP2004527489 A5 JP 2004527489A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- oral pharmaceutical
- composition according
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 10
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 5
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 3
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 3
- 238000001179 sorption measurement Methods 0.000 claims 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 210000000813 small intestine Anatomy 0.000 claims 2
- 239000007962 solid dispersion Substances 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- -1 5-chloroindol-2-ylsulfonyl Chemical group 0.000 claims 1
- 229940123583 Factor Xa inhibitor Drugs 0.000 claims 1
- PSTBXECIKAJFMC-UHFFFAOYSA-N [4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-(4-pyridin-4-ylphenyl)methanone Chemical compound C1=CC2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=NC=C1 PSTBXECIKAJFMC-UHFFFAOYSA-N 0.000 claims 1
- DJBPJIZCEJIUJR-UHFFFAOYSA-N [4-[(5-chloro-1h-indol-2-yl)sulfonyl]piperazin-1-yl]-(4-imidazol-1-ylphenyl)methanone Chemical compound C=1C2=CC(Cl)=CC=C2NC=1S(=O)(=O)N(CC1)CCN1C(=O)C(C=C1)=CC=C1N1C=CN=C1 DJBPJIZCEJIUJR-UHFFFAOYSA-N 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0104752.1A GB0104752D0 (en) | 2001-02-27 | 2001-02-27 | Pharmaceutical compositions |
| PCT/SE2002/000327 WO2002067904A1 (en) | 2001-02-27 | 2002-02-25 | Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004527489A JP2004527489A (ja) | 2004-09-09 |
| JP2004527489A5 true JP2004527489A5 (https=) | 2005-12-22 |
Family
ID=9909545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567272A Pending JP2004527489A (ja) | 2001-02-27 | 2002-02-25 | フタル酸ヒドロキシプロピルメチルセルロースポリマーの固体分散物を含む医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040138231A1 (https=) |
| EP (1) | EP1365746A1 (https=) |
| JP (1) | JP2004527489A (https=) |
| KR (1) | KR20040011469A (https=) |
| CN (1) | CN1533268A (https=) |
| BR (1) | BR0206960A (https=) |
| CA (1) | CA2435815A1 (https=) |
| GB (1) | GB0104752D0 (https=) |
| IL (1) | IL156830A0 (https=) |
| MX (1) | MXPA03006746A (https=) |
| NO (1) | NO20033782D0 (https=) |
| NZ (1) | NZ527080A (https=) |
| WO (1) | WO2002067904A1 (https=) |
| ZA (1) | ZA200305386B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| WO2004105728A2 (en) * | 2003-05-27 | 2004-12-09 | Ranbaxy Laboratories Limited | Solid dispersions of cefpodoxime proxetil and processes for their preparation |
| KR100531612B1 (ko) * | 2003-08-12 | 2005-11-28 | 경동제약 주식회사 | 지속성 탐스로신 정제의 제조방법 및 그에 따른 지속성탐스로신 정제 |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| JP2011516613A (ja) * | 2008-04-15 | 2011-05-26 | シェーリング コーポレイション | 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物 |
| ES2598178T5 (es) * | 2008-10-07 | 2023-12-26 | Kudos Pharm Ltd | Formulación farmacéutica 514 |
| US20170087134A1 (en) * | 2010-07-12 | 2017-03-30 | Salix Pharmaceuticals, Ltd | Formulations of rifaximin and uses thereof |
| CN104188893A (zh) * | 2014-08-18 | 2014-12-10 | 赵明亮 | 一种盐酸环丙沙星口服固体制剂及其制备工艺 |
| PT3518924T (pt) | 2016-09-30 | 2022-10-27 | Salix Pharmaceuticals Inc | Formas de dispersão sólidas de rifaximina |
| WO2025078941A1 (en) * | 2023-10-09 | 2025-04-17 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition of pirtobrutinib |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57120518A (en) * | 1981-01-19 | 1982-07-27 | Tanabe Seiyaku Co Ltd | Preparation of microcapsule |
| US5102668A (en) * | 1990-10-05 | 1992-04-07 | Kingaform Technology, Inc. | Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH |
| TW212139B (https=) * | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
| KR0182801B1 (ko) * | 1991-04-16 | 1999-05-01 | 아만 히데아키 | 고체 분산체의 제조방법 |
| WO1995005809A1 (en) * | 1993-08-20 | 1995-03-02 | Nippon Shinyaku Co., Ltd. | Gastric remaining preparation, swollen molding, and production process |
| PT1082321E (pt) * | 1998-05-02 | 2005-03-31 | Astrazeneca Ab | Derivados heterociclicos que inibem o factor xa |
| EP2415462A1 (en) * | 1999-12-23 | 2012-02-08 | Mayne Pharma International Pty Ltd. | Improved pharmaceutical compositions for poorly soluble drugs |
-
2001
- 2001-02-27 GB GBGB0104752.1A patent/GB0104752D0/en not_active Ceased
-
2002
- 2002-02-25 WO PCT/SE2002/000327 patent/WO2002067904A1/en not_active Ceased
- 2002-02-25 MX MXPA03006746A patent/MXPA03006746A/es unknown
- 2002-02-25 CN CNA028056256A patent/CN1533268A/zh active Pending
- 2002-02-25 NZ NZ527080A patent/NZ527080A/en unknown
- 2002-02-25 CA CA002435815A patent/CA2435815A1/en not_active Abandoned
- 2002-02-25 KR KR10-2003-7011174A patent/KR20040011469A/ko not_active Withdrawn
- 2002-02-25 BR BR0206960-1A patent/BR0206960A/pt not_active IP Right Cessation
- 2002-02-25 US US10/468,246 patent/US20040138231A1/en not_active Abandoned
- 2002-02-25 JP JP2002567272A patent/JP2004527489A/ja active Pending
- 2002-02-25 EP EP02700946A patent/EP1365746A1/en not_active Withdrawn
- 2002-02-25 IL IL15683002A patent/IL156830A0/xx unknown
-
2003
- 2003-07-11 ZA ZA200305386A patent/ZA200305386B/en unknown
- 2003-08-26 NO NO20033782A patent/NO20033782D0/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527489A5 (https=) | ||
| JP2012509263A5 (https=) | ||
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| JP2008520742A5 (https=) | ||
| JP2010501478A5 (https=) | ||
| JP2010511631A5 (https=) | ||
| JP2006526031A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| JP2010077141A5 (https=) | ||
| JP2005537854A5 (https=) | ||
| JP2006515838A5 (https=) | ||
| NO20052883L (no) | Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom. | |
| JP2004524316A5 (https=) | ||
| JP2016512825A5 (https=) | ||
| DE60215814D1 (de) | Vinylphenyl-derivate als glk-aktivatoren | |
| CA2417106A1 (en) | Piperazine derivatives | |
| CY1108788T1 (el) | Τριαζολοπυριδινυλσουλφανυλ παραγωγα ως αναστολεις ρ38 map κινασης | |
| JP2010530376A5 (https=) | ||
| JP2007091758A5 (https=) | ||
| JP2007522135A5 (https=) | ||
| CY1113566T1 (el) | Καρβαμοϋλο-κυκλοεξανια για τη θεραπευτικη αγωγη της οξειας μανιας | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| CY1107203T1 (el) | Χρηση αναστολεων της il - 18 για τη θεραπεια και/ή την προληψη καρδιακης νοσου | |
| CN115803328A (zh) | 哌嗪-2,3-二酮衍生物及其在医药上的应用 | |
| JP2008513510A5 (https=) |